Acalabrutinib, (R)-

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C26H23N7O2
Molecular Weight	465.5065
Optical Activity	UNSPECIFIED
Defined Stereocenters	1 / 1
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

CC#CC(=O)N1CCC[C@@H]1C2=NC(=C3N2C=CN=C3N)C4=CC=C(C=C4)C(=O)NC5=CC=CC=N5

InChI

InChIKey=WDENQIQQYWYTPO-LJQANCHMSA-N

InChI=1S/C26H23N7O2/c1-2-6-21(34)32-15-5-7-19(32)25-31-22(23-24(27)29-14-16-33(23)25)17-9-11-18(12-10-17)26(35)30-20-8-3-4-13-28-20/h3-4,8-14,16,19H,5,7,15H2,1H3,(H2,27,29)(H,28,30,35)/t19-/m1/s1

HIDE SMILES / InChI

Approval Year

Name

Type

Language

Acalabrutinib, (R)-

Common Name

English

Acalabrutinib enantiomer

Common Name

English

Benzamide, 4-[8-amino-3-[(2R)-1-(1-oxo-2-butyn-1-yl)-2-pyrrolidinyl]imidazo[1,5-a]pyrazin-1-yl]-N-2-pyridinyl-

Systematic Name

English

Code System Code Type Description

FDA UNII

6J82PAQ862

Created by admin on Sat Dec 16 18:16:24 GMT 2023 , Edited by admin on Sat Dec 16 18:16:24 GMT 2023

PRIMARY

PUBCHEM

121413436

Created by admin on Sat Dec 16 18:16:24 GMT 2023 , Edited by admin on Sat Dec 16 18:16:24 GMT 2023

PRIMARY

CAS

1952316-43-6

Created by admin on Sat Dec 16 18:16:24 GMT 2023 , Edited by admin on Sat Dec 16 18:16:24 GMT 2023

PRIMARY

SUBSTANCE RECORD


					6J82PAQ862

Acalabrutinib, (R)-